First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
Authors
Zixian Wang,
Junjie PengXinjun Liang,
Ying Cheng,
Yanhong Deng,
Kehe Chen,
Mingjun Zhang,
Jingdong Zhang,
Wei Wang,
Bangwei Cao,
Yongdong Jin,
Meili Sun,
Yuan Lin,
Suxia Luo,
Zhen Li,
Yang Liu,
Ying Ke,
Haoyu Yu,
Jin Li,
Li Wang,
Junwu Zhu,
Feng Wang +20 authors
,
Rui‐Hua Xu Tip Tip